Rankings / Mood, Anxiety & Stress

SSRIs (sertraline / escitalopram / fluoxetine)

Mood, Anxiety & Stress · Selective serotonin reuptake inhibitor

Tier B

Reviewed by Read Off Label · Last reviewed · How we grade

serotoninbdnfprescription
6.6 / 10
Tier B
Ev 8 Bn 6.5 Sf 5

Bottom line

Read Off Label grades SSRIs (sertraline / escitalopram / fluoxetine) as B (6.6/10) based on strong evidence, moderate-strong benefit magnitude, and a med-risk safety profile.

Workhorse antidepressant class; ~75% of US antidepressant Rx.

Studied, labeled, or reported-use context: Sertraline 25-200 mg; escitalopram 5-20 mg; fluoxetine 10-80 mg PO daily — Rx; not individualized guidance.

What the evidence says

Workhorse antidepressant class; ~75% of US antidepressant Rx. Kirsch 2008 meta debate remains unresolved for mild cases; STAR*D and more recent reanalyses support modest effect in moderate-severe. PSSD (post-SSRI sexual dysfunction) is a growing patient-report phenomenon with emerging acknowledgment. Cipriani 2018 network meta-analysis ranks among the most-cited efficacy comparisons.

Mechanism

Block SERT transporter → elevated synaptic serotonin → downstream BDNF, neuroplasticity, HPA axis modulation over weeks; class effect on depression and anxiety

Studied, labeled, or reported dose & route

Sertraline 25-200 mg; escitalopram 5-20 mg; fluoxetine 10-80 mg PO daily

This records doses and routes described in studies, approved labeling, clinical practice, or documented use. It is not individualized guidance and does not establish safety; context changes with indication, formulation, health history, monitoring, and other medicines.

Citations

A link means the source informed this entry; it does not mean every claim on the page comes from that source. If a citation looks wrong or you want a claim re-checked, send a correction.

Common questions

What does the evidence show about SSRIs (sertraline / escitalopram / fluoxetine)'s effects?
Read Off Label rates the evidence for SSRIs (sertraline / escitalopram / fluoxetine) as Strong and the benefit magnitude as moderate-strong, producing an overall grade of B (6.6/10). Workhorse antidepressant class; ~75% of US antidepressant Rx.
What safety findings are reported for SSRIs (sertraline / escitalopram / fluoxetine)?
SSRIs (sertraline / escitalopram / fluoxetine) has a med risk profile in the database. Med (sexual dysfunction — ~30-50% and may persist after discontinuation as PSSD; emotional blunting; GI; weight changes; discontinuation syndrome; small QT risk — citalopram; bleeding with NSAIDs; serotonin syndrome with MAOIs) Legal status: Rx.
What doses or routes are reported for SSRIs (sertraline / escitalopram / fluoxetine)?
Sertraline 25-200 mg; escitalopram 5-20 mg; fluoxetine 10-80 mg PO daily This is context from studies, approved labeling, clinical practice, or documented use; it is not individualized guidance and does not establish safety.
How does SSRIs (sertraline / escitalopram / fluoxetine) work?
Block SERT transporter → elevated synaptic serotonin → downstream BDNF, neuroplasticity, HPA axis modulation over weeks; class effect on depression and anxiety

This is an independent synthesis of published research by a non-clinician. Scores are opinions supported by citations, not prescriptions. See the full disclaimer and methodology for how this score was produced and what it does and doesn't mean.